Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

14 Large-Cap Stocks Expected to Grow the Most $AAPL $CF $CLF $DTV $INTC $MA $V

We compiled the list of top 14 large cap growth stocks where earnings are expected to grow by at least 20% over the next five years. The data is sourced from Yahoo Finance and Finviz. Here are the 14 stocks:

Altera Corporation

1. Altera Corporation (ALTR): Altera Corporation is a semiconductor company. ALTR recently traded at $36.54 and has a 0.9% dividend yield. ALTR gained 47.52% during the past 12 months. The stock has a market cap of $11.8 billion and a P/E ratio of 13.34. Altera’s estimated EPS growth over the next 5 years is 24.7%. Jim Simons’ Renaissance Technologies had $164 million invested in ALTR shares at the end of March. Jim Simon’s Medallion Fund, has not realized negative returns since 1990.

2. Apple Inc. (AAPL): Apple produces and markets personal computers, mobile communication and media devices. AAPL recently traded at $376.99 and gained 51.34% during the past 12 months. The stock has a market cap of $349.5 billion, P/E ratio of 14.92 and estimated EPS growth over the next 5 years at 61.1%. Rob Citrone’s Discovery Capital Management had $633 million invested in AAPL at the end of March.

Read the rest of the article here.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!